Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer Patients: Does the Use of Erythropoiesis-Stimulating Agents Worsen Survival?

Rodney P. Rocconi; Paula Sullivan; Beverly Long; Marie Blaize; Jennifer Brown; Janeen Arbuckle; Kerri Bevis; Jacob M. Estes; Eddie Reed; Michael A. Finan

doi:10.1097/IGC.0b013e31825104f4

Article info

Ovarian Cancer

Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer Patients: Does the Use of Erythropoiesis-Stimulating Agents Worsen Survival?

Authors

Rodney P. Rocconi Mitchell Cancer Institute, University of South Alabama, Mobile; and PubMed articles Google scholar articles
Paula Sullivan Mitchell Cancer Institute, University of South Alabama, Mobile; and PubMed articles Google scholar articles
Beverly Long Mitchell Cancer Institute, University of South Alabama, Mobile; and PubMed articles Google scholar articles
Marie Blaize University of Alabama at Birmingham, Birmingham, AL. PubMed articles Google scholar articles
Jennifer Brown University of Alabama at Birmingham, Birmingham, AL. PubMed articles Google scholar articles
Janeen Arbuckle University of Alabama at Birmingham, Birmingham, AL. PubMed articles Google scholar articles
Kerri Bevis University of Alabama at Birmingham, Birmingham, AL. PubMed articles Google scholar articles
Jacob M. Estes University of Alabama at Birmingham, Birmingham, AL. PubMed articles Google scholar articles
Eddie Reed Mitchell Cancer Institute, University of South Alabama, Mobile; and PubMed articles Google scholar articles
Michael A. Finan Mitchell Cancer Institute, University of South Alabama, Mobile; and PubMed articles Google scholar articles

Address correspondence and reprint requests to Rodney P. Rocconi, MD, Mitchell Cancer Institute, University of South Alabama, 1660 Springhill Ave, Mobile, AL. E-mail: rocconi@usouthal.edu.

Citation

Rocconi RP, Sullivan P, Long B, et al

Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer Patients: Does the Use of Erythropoiesis-Stimulating Agents Worsen Survival?

International Journal of Gynecologic Cancer 2012;22:786-791.

Publication history

Received December 2, 2011
First published June 1, 2012.

Online issue publication

February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password